EGFR and colorectal cancer: Interestingly, cell-free DNA sequencing detected the Q61H mutation in 52% of colorectal cancer patients who developed resistance to anti-EGFR monoclonal antibody (mAb) treatment (Cetuximab and Panitumumab)36.